SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

EVAA Protocol

EVAA Protocol ($EVAA) is trending as community members discuss recent price movements and potential shorting opportunities based on technical analysis. Some users are pointing to potential risks, with discussions around possible scams, while others highlight its performance within the TON ecosystem.

DTE Energy Co. operates as a diversified energy company, which engages in the development and management of energy-related businesses and services. It operates through the following segments: Electric, Gas, DTE Vantage, Energy Trading, and Corporate and Other. The Electric segment consists of generation, purchase, distribution, and sale of electricity to residential, commercial, and industrial customers in southeastern Michigan. The Gas segment is involved in the purchase, storage, transportation, distribution, and sale of natural gas to residential, commercial, and industrial customers throughout Michigan, and the sale of storage and transportation capacity. The DTE Vantage segment focuses on projects that deliver energy and utility-type products and services to industrial, commercial, and institutional customers, produce reduced emissions fuel, and sell electricity and pipeline-quality gas from renewable energy projects. The Energy Trading segment covers energy marketing and trading operations. The Corporate and Other segment includes various holding company activities, holds certain non-utility debt, and holds certain investments, as well as funds supporting regional development and economic growth. The company was founded in January 1995 and is headquartered in Detroit, MI.

DTE Energy Co.

DTE Energy is trending due to a mix of factors, including analyst rating adjustments and discussions around the company's investments in clean energy and infrastructure. The community is focused on the balance between growth initiatives, debt, and potential risks, while also noting the hyperscale data center agreement and potential for increased energy demand.

Zcash is a decentralized and open-source cryptocurrency that offers privacy and selective transparency of transactions. Zcash payments are published on a public blockchain, but the sender, recipient, and amount of a transaction remain private.  Zcash is based on peer-reviewed cryptographic research, and built by a security-specialized engineering team on an open source platform based on Bitcoin Core's battle-tested codebase. Our improvement over Bitcoin is the addition of privacy. Zcash uses advanced cryptographic techniques, namely zero-knowledge proofs, to guarantee the validity of transactions without revealing additional information about them.  How Zcash works  Zcash encrypts the contents of shielded transactions. Since the payment information is encrypted, the protocol uses a novel cryptographic method to verify their validity.  Zcash uses a zero-knowledge proof construction called a zk-SNARK, developed by our team of experienced cryptographers based on recent breakthroughs in cryptography. These constructions allow the network to maintain a secure ledger of balances without disclosing the parties or amounts involved. Instead of publicly demonstrating spend-authority and transaction values, the transaction metadata is encrypted and zk-SNARKs are used to prove that nobody is cheating or stealing.  Zcash also enables users to send public payments which work similarly to Bitcoin. With the support for both shielded and transparent addresses, users can choose to send Zcash privately or publicly. Zcash payments sent from a shielded address to a transparent address reveal the received balance, while payments from a transparent address to a shielded address protect the receiving value.   Check out CoinBureau for guide on What is ZCash.

Zcash

Zcash is trending due to a significant price surge, sparking debates about its potential as 'the new Bitcoin' and the impact of its privacy features. Community members are actively discussing entry and exit strategies amidst the volatility, while also comparing it to other cryptocurrencies.

Dave, Inc. is a digital banking service. Its products include a budgeting tool to help members manage their upcoming bills to avoid overspending, cash advances through its flagship ExtraCash product to help members avoid punitive overdraft fees, a Side Hustle product, where Dave helps connect members with supplemental work opportunities, and Dave Banking, a modern checking account experience with valuable tools for building long-term financial health. The company was founded by Jason Wilk, Paras Chitrakar, and John Wolanin in October 2015 and is headquartered in Los Angeles, CA.

Dave Inc - Ordinary Shares - Class A

DAVE is trending due to a Department of Justice lawsuit alleging deceptive practices, with potential consumer redress exceeding $200 million, sparking concerns about the company's future. Despite this legal challenge, some community members remain optimistic, pointing to upcoming BNPL initiatives and strong Q3 2025 adjusted EBITDA margins. Recent analyst target price increases add to the mixed sentiment surrounding the stock.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is trending as the community discusses its potential for a violent move upwards and compares it to other cryptocurrencies like Zcash. Conversations also highlight accumulation patterns and speculation about an impending alt season, alongside discussions of potential ETF filings. Some traders are pointing to the BCH/BTC chart, suggesting an undervaluation compared to Bitcoin.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending as the community analyzes its recent earnings report and future prospects in the competitive AI landscape. Wedbush analyst Dan Ives' bullish stance, calling SOUN an "underappreciated pure play AI company" with an outperform rating, is a key talking point. Discussions also revolve around the company's partnerships and potential impact from external factors like the government shutdown.

Spark is an onchain capital allocator, with $3.86B deployed across DeFi, CeFi, and RWA. It unlocks capital efficiency at scale, auto-balancing allocations based on market conditions while maintaining a conservative risk profile. Spark was created to solve DeFi’s core inefficiencies: fragmented liquidity, unstable yields, and idle stablecoin capital. It acts as a two-sided capital allocator—borrowing from Sky’s $6.5B+ reserves and deploying across DeFi, CeFi, and RWAs to provide deep, consistent liquidity. This yield is packaged into products like sUSDS and sUSDC, offering users programmable, fee-free income. Rather than competing with protocols, Spark powers them as the liquidity and yield infrastructure for onchain finance.  Access to Deep, Scalable Liquidity: Spark taps into Sky’s $6.5B+ stablecoin reserves, enabling large-scale capital deployment across DeFi, CeFi, and RWAs. User-Friendly Yield Products: Yield is delivered through stablecoins like sUSDS and sUSDC—fully composable, fee-free, and available across chains.  SparkLend: A stablecoin lending market. Unlike other lending protocols where rates fluctuate based on utilization or loan size, SparkLend offers governance-defined rates that do not vary based on those factors. This is made possible by Spark’s Liquidity Layer (SLL), which supplies consistent stablecoin liquidity to the protocol.  Spark Savings: A product for earning yield on stablecoins like USDC, and USDS (and soon, USDT) by converting them into yield-bearing sUSDS or sUSDC. These yield tokens are composable with other DeFi protocols, making it easy to put capital to work while maintaining exposure to onchain yield at a competitive risk-adjusted rate.  Spark Liquidity Layer (SLL): A backend capital allocator that routes liquidity to other protocols like Aave, Morpho, and even RWAs (e.g., BlackRock’s BUIDL). One of the most important SLL deployments on Base is the Spark USDC Morpho Vault, which currently supplies $95M USDC, making it the largest liquidity provider to the Coinbase app integration on Base. This vault plays a key role in mitigating rate volatility for borrowers and demonstrates how SLL enhances liquidity conditions across DeFi.  Existing Products: Spark's total TVL is currently $7.9B, split between SparkLend and the Spark Liquidity Layer (SLL). You can find real-time details and breakdowns here: https://defillama.com/protocol/spark#information  Spark in DeFiLlama, https://defillama.com/protocol/spark#information  SparkLend is one of the largest lending protocols in DeFi. It offers deep liquidity and governance-defined rates, providing borrowers with transparent conditions.  Spark Savings is live on Ethereum mainnet, Base, Optimism, Arbitrum, Unichain, and Gnosis, offering vaults for both USDS and USDC.  The Spark Liquidity Layer actively deploys capital across protocols on multiple chains, including Ethereum mainnet, Base, and Arbitrum.  SLL allocations in real-time, https://data.spark.fi/spark-liquidity-layer

Spark

Spark (SPK) is trending as community members discuss its potential for a breakout, pointing to recent news and a roadmap including SparkLend expansions and Savings V2. Speculation is fueled by its low market cap, recent positive price movement, and high trading volume, with some anticipating a retest of previous highs and others suggesting it's oversold.

MBIA, Inc. is a holding company, which engages in the provision of financial guarantee insurance, related reinsurance, advisory and portfolio services, and asset management advisory services. It operates through the following business segments: U.S. Public Finance Insurance, Corporate, and International and Structured Finance Insurance. The U.S. Public Finance Insurance segment issues financial guarantees for municipal bonds, including tax-exempt and taxable indebtedness of U.S. political subdivisions through its National subsidiary. The Corporate segment consists of general corporate activities including providing general support services to MBIA's other operating businesses and asset and capital management. The International and Structured Finance Insurance segment includes the operation of MBIA Corp. The company was founded in 1973 and is headquartered in Purchase, NY.

MBIA Inc.

MBI is trending due to its announcement of a special $8 per share dividend, sparking discussions around the stock's potential price movement and the implications for shareholders. The community is weighing the opportunity to capture the dividend against concerns about a potential price drop post-payout, with some speculating about a potential acquisition by $AGO given its current financial state and PREPA claims.

Expedia Group, Inc. is an online travel company, which engages in the provision of travel products and services to leisure and corporate travelers. It operates through the following segments: B2C, B2B, and Trivago. The B2C segment offers a full range of travel and advertising services to worldwide customers through a variety of consumer brands. The B2B segment refers to a wide range of travel and non-travel companies including airlines, offline travel agents, online retailers, corporate travel management, and financial institutions. The Trivago segment generates advertising revenue primarily from sending referrals to online travel companies and travel service providers from hotel metasearch websites. The company was founded in 1994 and is headquartered in Seattle, WA.

Expedia Group Inc

Expedia Group is trending due to speculation of a potential acquisition by Uber, fueling a surge in the stock price as investors weigh the implications of a combined travel and transportation super-app. Community discussions revolve around the potential synergies and strategic fit, while analysts debate whether the deal aligns with Uber's core growth objectives. Some investors express concerns about insider selling, while others point to Expedia's attractive valuation relative to peers like Booking Holdings.

CoreCivic, Inc. operates as a government solutions company, which engages in the development and management of prisons and other correctional facilities. It operates through the following segments: Safety, Community, and Properties. The Safety segment consists of correctional and detention facilities. It provides transportation services to government agencies and TransCoR. The Community segment offers residential reentry centers and provides electronic monitoring case management services. The Properties segment consists of real estate properties owned by the company that are leased to government agencies. The company was founded by Thomas W. Beasley, T. Don Hutto, and Robert Crants on January 28, 1983 and is headquartered in Brentwood, TN.

CoreCivic Inc

CoreCivic ($CXW) is trending amid positive analyst updates, solid earnings reports, and discussion around government contracts. The community is focused on the potential for increased demand for CoreCivic's services, especially related to immigration policy shifts. Some are drawing comparisons to sector peer GEO Group and speculating about potential acquisitions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Y Intercept Hong Kong Ltd Acquires New Position in Disc Medicine, Inc. $IRON

Y Intercept Hong Kong Ltd bought a new position in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and...

What Makes Disc Medicine, Inc. (IRON) a Strong Momentum Stock: Buy Now?

Does Disc Medicine, Inc. (IRON) have what it takes to be a top stock pick for momentum investors? Let's find out.

Does Disc Medicine, Inc. (IRON) Have the Potential to Rally 26.29% as Wall Street Analysts Expect?

The consensus price target hints at a 26.3% upside potential for Disc Medicine, Inc. (IRON). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Shares of Revolution Medicines, Disc Medicine, and Regeneron Pharmaceuticals rose in after-hours trading on Thursday after the U.S. Food and Drug Administration (FDA) announced the first group of drugs selected for expedited review under its new National Priority Voucher pilot program.In after-hours trading on Thursday,&nbsp;<a href="https://stocktwits.com/symbol/RVMD">Revolution Medicines</a> jumped 9%,&nbsp;<a href="https://stocktwits.com/symbol/IRON">Disc Medicine</a> surged 17%, and&nbsp;<a href="https://stocktwits.com/symbol/REGN">Regeneron Pharmaceuticals</a> edged up 0.1%.FDA Names 9 Drugs For Accelerated ReviewThe FDA said nine products have been chosen for the fast-track review process, which shortens decision timelines from the usual 10–12 months to just one or two months once a complete application is filed.The selected drugs include Merck KGaA’s fertility treatment Pergoveris, Sanofi’s Type 1 diabetes therapy teplizumab, Regeneron’s gene therapy DB-OTO for congenital deafness, and ketamine for domestic manufacturing of a general anesthetic.&nbsp;Also on the list are Revolution Medicines’ RMC-6236 for pancreatic cancer, Disc Medicine’s bitopertin for porphyria, Achieve Life Sciences’ cytisinicline for nicotine vaping addiction, Dompe’s cenegermin-bkbj for blindness, and Augmentin XR for domestic manufacturing of a common antibiotic.FDA Commissioner Highlights Expedited Review EffortFDA Commissioner Marty Makary said the initiative could shorten FDA decision times from a year to "a matter of weeks” by moving promising or high-impact therapies to the front of the review line.Makary said some of the drugs selected for vouchers, including one that uses ketamine as a general anesthetic, will be manufactured in the United States. He described Regeneron’s DB-OTO, a gene therapy for congenital deafness, as “an exciting treatment,” noting that “some of these kids got normal hearing from this amazing treatment.”He added that this is just the first round of vouchers, with additional selections expected in the coming weeks.How Stocktwits Traders Reacted To FDA’s Fast-Track ListOn Stocktwits, retail sentiment toward Revolution Medicines was ‘extremely bullish’ with ‘extremely high’ message volume, while Disc Medicine saw ‘neutral’ sentiment amid similarly ‘extremely high’ activity, and Regeneron registered ‘neutral’ sentiment with ‘normal’ engagement levels.One&nbsp; user said they expect Regeneron shares to climb steadily, projecting the stock could reach the $800-$900 range within two years.&nbsp;<stembedurl>https://stocktwits.com/Iwannagofast1/message/632653980</stembedurl>Another bullish trader suggested Revolution Medicines could be an attractive takeover candidate, potentially fetching twice its current value.<stembedurl>https://stocktwits.com/ChessGM/message/632555600</stembedurl>So far this year, Revolution Medicines shares have gained 14%, Disc Medicine is up 17%, while Regeneron has declined 20%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the FDA (United States Food and Drug Administration) logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Revolution Medicines, Disc Medicine, Regeneron Stocks Jump After-Hours As FDA Fast-Tracks 9 Drugs Under New Review Program

The FDA’s new National Priority Voucher pilot helps with faster drug reviews, cutting timelines from nearly a year to weeks.

Equity

Raymond James bullish on biotech firms on favorable valuation

Investing.com -- Raymond James started coverage on biotechnology companies, rating Avidity Biosciences and Disc Medicine at Strong Buy and assigning Outperform ratings to Dyne Therapeutics, Tectonic Therapeutic, and Wave Life Sciences (NASDAQ:WVE), pointing to a sector-wide opportunity amid “suppressed valuations.”

Disc Medicine (NASDAQ:IRON) Given "Outperform" Rating at Wedbush

Wedbush reaffirmed their outperform rating on shares of Disc Medicine (NASDAQ:IRON - Free Report) in a report issued on Monday morning, RTT News reports. Wedbush currently has a $43.00 price...

FY2024 Earnings Estimate for Disc Medicine, Inc. Issued By Wedbush (NASDAQ:IRON)

Disc Medicine, Inc. (NASDAQ:IRON - Free Report) - Wedbush boosted their FY2024 earnings per share (EPS) estimates for Disc Medicine in a report released on Monday, April 1st. Wedbush analyst D...

Leerink Partnrs Comments on Disc Medicine, Inc.'s Q2 2024 Earnings (NASDAQ:IRON)

Disc Medicine, Inc. (NASDAQ:IRON - Free Report) - Stock analysts at Leerink Partnrs reduced their Q2 2024 earnings per share estimates for shares of Disc Medicine in a report issued on Monday, April...

Raymond James Reiterates "Outperform" Rating for Disc Medicine (NASDAQ:IRON)

Disc Medicine (NASDAQ:IRON - Get Free Report)s stock had its "outperform" rating reaffirmed by analysts at Raymond James in a report issued on Monday, Marketbeat Ratings reports. They...

Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Natera (NTRA) and Disc Medicine (IRON)

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Assembly Biosciences (ASMB Research Report), Nater...

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.

Disc Medicine Inc

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

Current Price	$83.85
Prev Close	$87.00
Open	$87.00
Dividend Yield	0.00%
50-Day Moving Average	$71.70
Beta	1.02
Avg. Volume	577,169.83
PE Ratio	-18.74

52-Week High	$95.95
52-Week Low	$30.82
Market Capitalization	$3.13B
EPS (Annual)	-$3.96
Price to Book	5.12
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

IRON
Disc Medicine Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IRON News

IRONDisc Medicine Inc